BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29982661)

  • 1. Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands' Susceptibility Gene Mutation Status.
    Antwi SO; Fagan SE; Chaffee KG; Bamlet WR; Hu C; Polley EC; Hart SN; Shimelis H; Lilyquist J; Gnanaolivu RD; McWilliams RR; Oberg AL; Couch FJ; Petersen GM
    J Natl Cancer Inst; 2019 Mar; 111(3):264-271. PubMed ID: 29982661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Cancer Susceptibility Gene Mutations and ABO Blood Group of Pancreatic Cancer Probands on Concomitant Risk to First-Degree Relatives.
    Antwi SO; Rabe KG; Bamlet WR; Meyer M; Chandra S; Fagan SE; Hu C; Couch FJ; McWilliams RR; Oberg AL; Petersen GM
    Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):372-381. PubMed ID: 34782396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of malignancy in first-degree relatives of patients with pancreatic carcinoma.
    McWilliams RR; Rabe KG; Olswold C; De Andrade M; Petersen GM
    Cancer; 2005 Jul; 104(2):388-94. PubMed ID: 15912495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants.
    Chen X; Meyer MA; Kemppainen JL; Horibe M; Chandra S; Majumder S; Petersen GM; Rabe KG
    JAMA Oncol; 2023 Jul; 9(7):955-961. PubMed ID: 37200008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers.
    Mukherjee B; Delancey JO; Raskin L; Everett J; Jeter J; Begg CB; Orlow I; Berwick M; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Culver HA; Rosso S; Zanetti R; Kanetsky PA; From L; Gruber SB;
    J Natl Cancer Inst; 2012 Jun; 104(12):953-6. PubMed ID: 22534780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Probands to Relatives: Communication of Genetic Risk for Hereditary Breast-Ovarian Cancer and Its Influence on Subsequent Testing.
    Seven M; Shah LL; Yazici H; Daack-Hirsch S
    Cancer Nurs; 2022 Jan-Feb 01; 45(1):E91-E98. PubMed ID: 32804756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status.
    Loman N; Bladström A; Johannsson O; Borg A; Olsson H
    Breast Cancer Res; 2003; 5(6):R175-86. PubMed ID: 14580253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic cancer risk to siblings of probands in bilineal cancer settings.
    Rabe KG; Stevens MA; Hernández AT; Chandra S; Hubbard JM; Kemppainen JL; Majumder S; Petersen GM
    Genet Med; 2022 May; 24(5):1008-1016. PubMed ID: 35227607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
    Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K
    J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial pancreatic cancer risk: a population-based study in Utah.
    Kohli DR; Smith KR; Wong J; Yu Z; Boucher K; Faigel DO; Pannala R; Burt RW; Curtin K; Samadder NJ
    J Gastroenterol; 2019 Dec; 54(12):1106-1112. PubMed ID: 31240435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations.
    Lee JS; John EM; McGuire V; Felberg A; Ostrow KL; DiCioccio RA; Li FP; Miron A; West DW; Whittemore AS
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):359-63. PubMed ID: 16492929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of family history of specific cancers with a younger age of onset of pancreatic adenocarcinoma.
    McWilliams RR; Bamlet WR; Rabe KG; Olson JE; de Andrade M; Petersen GM
    Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1143-7. PubMed ID: 16861052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer.
    Stadler ZK; Salo-Mullen E; Patil SM; Pietanza MC; Vijai J; Saloustros E; Hansen NA; Kauff ND; Kurtz RC; Kelsen DP; Offit K; Robson ME
    Cancer; 2012 Jan; 118(2):493-9. PubMed ID: 21598239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated cancer mortality in the relatives of patients with pancreatic cancer.
    Wang L; Brune KA; Visvanathan K; Laheru D; Herman J; Wolfgang C; Schulick R; Cameron JL; Goggins M; Hruban RH; Klein AP
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2829-34. PubMed ID: 19843679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncology clinic-based germline genetic testing for exocrine pancreatic cancer enables timely return of results and unveils low uptake of cascade testing.
    Wang Y; Golesworthy B; Cuggia A; Domecq C; Chaudhury P; Barkun J; Metrakos P; Asselah J; Bouganim N; Gao ZH; Chong G; Foulkes WD; Zogopoulos G
    J Med Genet; 2022 Aug; 59(8):793-800. PubMed ID: 34556502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-Based Relative Risks for Lung Cancer Based on Complete Family History of Lung Cancer.
    Cannon-Albright LA; Carr SR; Akerley W
    J Thorac Oncol; 2019 Jul; 14(7):1184-1191. PubMed ID: 31075544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline mutation prevalence in individuals with pancreatic cancer and a history of previous malignancy.
    Dudley B; Karloski E; Monzon FA; Singhi AD; Lincoln SE; Bahary N; Brand RE
    Cancer; 2018 Apr; 124(8):1691-1700. PubMed ID: 29360161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial risk and clustering of nasopharyngeal carcinoma in Guangdong, China.
    Jia WH; Feng BJ; Xu ZL; Zhang XS; Huang P; Huang LX; Yu XJ; Feng QS; Yao MH; Shugart YY; Zeng YX
    Cancer; 2004 Jul; 101(2):363-9. PubMed ID: 15241835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.